With $30 million in funding, Dallas startup will speed gene therapy clinical trials

A new biotech startup in Dallas aims to speed the development of treatments for rare neurological diseases that disproportionately affect children. Taysha Gene Therapies, launched Tuesday with $30 million in seed financing, has partnered with UT Southwestern researchers whose mission is to eradicate genetic diseases that can deprive children of the ability to walk, talk,…

Read More